Our Business Model

UDG Healthcare is a global leader in healthcare advisory, communications, commercial, clinical and packaging services. We are an industry-leading partner of choice for healthcare companies seeking expert outsourcing services. Our business model revolves around continuously improving our core businesses and identifying and acquiring strong businesses that complement and add value.


We continue to strengthen employee skills, communication and engagement and foster an environment which empowers our people to execute our business model successfully.

Number of employees 8,700+


Our strong balance sheet supports the delivery of continued growth through M&A, to supplement organic growth. We are continuously identifying and acquiring highly complementary businesses that drive value and generate attractive returns. In 2018, we completed two acquisitions, following the completion of six acquisitions in 2017.

M&A spend $82.4m

Facilities and Infrastructure

We are well positioned to execute our business model, having a robust operating platform, a diverse geographical footprint and the capability to consistently improve our client offering through our state-of-the art facilities.

Capital expenditure $60.6m

Stakeholders and Relationships

We work as a proactive and long-term business partner with our clients, delivering integrated healthcare services solutions based on market foresight, contributing to better business for our stakeholders.

Number of clients 300+

Delivering Sustainable Growth

Profit and Cash Generation

Both Ashfield and Sharp are focused on growing profits organically and through acquisitions, and maximising cash conversion from our operations to support the development and execution of our strategy.

Capital Deployment

Disciplined financial management allows for ongoing reinvestment in the business to sustain our growth model and capitalise on the opportunity to grow our services.

Shareholder Value

Successful delivery of our strategy results in increased shareholder value and progressive dividend growth.

Our people value

The Group is organised and managed across two separate divisions:

Ashfield logo Ashfield logo


Our focus is to be a leading international partner of choice so that together with our clients we can help improve the lives of patients.

We partner with the top 30 global pharmaceutical companies 30


Our business model delivers sustainable long-term value for our shareholders and we operate a progressive dividend policy.

Dividend to shareholders $34.7m


We are committed to investing in our employees’ career development to ensure they can perform in their roles to the highest standards.

Remuneration to employees $614.2m


Our service offering provides patients with insights and solutions to help improve their lives.

Number of active patient support programmes globally 70+

Local Communities

In addition to selecting three official charity organisations every year we partner with a significant number of charity groups globally.

Number of charities supported globally c.70
Our values are what sets us apart

For us, only the best is good enough. Quality underpins everything we say and everything we do. We set high standards, develop our people and deliver a quality service that will surpass our clients’ expectations.


We build on trust through delivering on our promises. We work in partnership with each other and with our clients. This way, we build relationships, based on trust, integrity and transparency.


We are committed to solving problems and resourcefully thinking every day. We build solutions for our clients using creativity and innovation.


Together we have a wealth of knowledge and skills built over many years. Through strong business and financial leadership, we deliver excellence and enhance our client experience.


We achieve our clients’ goals with imagination and passion. We are enthusiastic for success, always ensuring we engage, listen and work together to build the best solutions.